Healthcare company Healius (ASX:HLS) changed the terms of employment of Chief Executive Officer Paul Anderson, according to a Monday filing with the Australian bourse.

The CEO's tenure will now move to "permanent ongoing employment, subject to termination," from a fixed term ending June 30, 2026.

Anderson's fixed annual remuneration will also be increased to AU$1.3 million from AU$1.1 million, effective Jan. 1.

Further, the CEO's fiscal year 2027 bonus arrangements will include short- and long-term incentives to align with the remuneration structure for other key management personnel, pending performance measures, the filing said.